Mark L. Levitt
Direttore Tecnico/Scientifico/R&S presso REDHILL BIOPHARMA LTD.
Profilo
Mark L.
Levitt is currently the Director at EnGeneIC Pty Ltd.
and the Chief Scientific Officer at RedHill Biopharma Ltd.
He previously worked as the Director at UPMC Cancer Institute and as the Head-Lung Cancer Unit at Sheba Medical Center.
Posizioni attive di Mark L. Levitt
Società | Posizione | Inizio |
---|---|---|
REDHILL BIOPHARMA LTD. | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mark L. Levitt
Società | Posizione | Fine |
---|---|---|
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services UPMC Cancer Institute provides health care and insurance services. The company was founded in 1985 and is headquartered in Pittsburgh, PA. | Direttore/Membro del Consiglio | - |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
REDHILL BIOPHARMA LTD. | Health Technology |
Aziende private | 3 |
---|---|
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Health Technology |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Health Services |
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services UPMC Cancer Institute provides health care and insurance services. The company was founded in 1985 and is headquartered in Pittsburgh, PA. | Health Services |
- Borsa valori
- Insiders
- Mark L. Levitt